Verition Fund Management LLC 89bio, Inc. Transaction History

Verition Fund Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.31 - $10.9 $151,960 - $226,589	20,788 New	20,788 $166,000
Q1 2023 May 15, 2023	BUY	$10.48 - $16.94 $342,329 - $553,345	32,665 New	32,665 $497,000
Q2 2021 Aug 16, 2021	SELL	$17.42 - $28.0 $1.86 Million - $2.99 Million	-106,731 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$20.22 - $26.73 $2.16 Million - $2.85 Million	106,731 New	106,731 $2.53 Million

158

108M

73.6K

1.19M

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $387M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.